Crohn's disease patients with chronic intestinal failure receiving long-term parenteral nutrition: A cross-national adult study

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 8, 2011, Pages 931-940

  Elriz, K ^a   Palascak Juif, V ^b   Joly, F ^c   Seguy, D ^d   Beau, P ^e   Chambrier, C ^f   Boncompain, M ^f   Fontaine, E ^g   Laharie, D ^h   Savoye, G ^a   Lerebours, E ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c BEAUJON HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ENTERIC FEEDING; FEMALE; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; INTESTINE STENOSIS; LONG TERM CARE; MALE; MULTICENTER STUDY; ONSET AGE; OUTCOME ASSESSMENT; PANCREATITIS; PANCYTOPENIA; PARENTERAL NUTRITION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SMALL INTESTINE RESECTION; TOXIC HEPATITIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHRONIC DISEASE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; INTESTINE, SMALL; MALE; MIDDLE AGED; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHORT BOWEL SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 80053206227     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04806.x     Document Type: Article

References (61)

1. Basilisco G, Campanini M, Cesana B, et al. Risk factors for first operation in Crohn's disease. Am J Gastroenterol 1989; 84: 749-52. (Pubitemid 19184376)
2. Bernell O, Lapidus A, Hellers G,. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000; 231: 38-45. (Pubitemid 30043937)
3. Bernell O, Lapidus A, Hellers G,. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000; 87: 1697-701.
4. Henriksen M, Jahnsen J, Lygren I, et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007; 42: 602-10. (Pubitemid 46633816)
5. Vernier-Massouille G, Balde M, Salleron J, et al. Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008; 135: 1106-13.
6. Avidan B, Sakhnini E, Lahat A, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 2005; 72: 248-53. (Pubitemid 41820810)
7. Lindhagen T, Ekelund G, Leandoer L, et al. Recurrence rate after surgical treatment of Crohn's disease. Scand J Gastroenterol 1983; 18: 1037-44. (Pubitemid 14200831)
8. Nordgren SR, Fasth SB, Oresland TO, et al. Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Scand J Gastroenterol 1994; 29: 1122-8. (Pubitemid 24374804)
9. Olaison G, Smedh K, Sjodahl R,. Recurrence of Crohn's disease in the neo-terminal ileum and colonic factors. Lancet 1991; 338: 1401.
10. Whelan G, Farmer RG, Fazio VW, et al. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985; 88: 1826-33. (Pubitemid 15052294)
11. Lennard-Jones JE,. Review article: practical management of the short bowel. Aliment Pharmacol Ther 1994; 8: 563-77.
12. Lal S, Teubner A, Shaffer JL,. Review article: intestinal failure. Aliment Pharmacol Ther 2006; 24: 19-31. (Pubitemid 43894002)
13. Messing B, Landais P, Goldfarb B, et al. Home parenteral nutrition for adults. Results of a multicenter survey in France. Presse Med 1988; 17: 845-9.
14. Messing B, Barnoud D, Beau P, et al. A 1993-1995 epidemiological survey of home parenteral nutrition in approved centers for adults in France. Gastroenterol Clin Biol 1998; 22: 413-8. (Pubitemid 28259465)
15. Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 2011; 60: 17-25.
16. Ugur A, Marashdeh BH, Gottschalck I, et al. Home parenteral nutrition in Denmark in the period from 1996 to 2001. Scand J Gastroenterol 2006; 41: 401-7. (Pubitemid 43675405)
17. Puiggros C, Chicharro ML, Gomez-Candela C, et al. Spanish registry of home-based parenteral nutrition during 2006 (NADYA-SENPE Group). Nutr Hosp 2008; 23: 6-11. (Pubitemid 351872267)
18. Green CJ, Mountford V, Hamilton H, et al. A 15-year audit of home parenteral nutrition provision at the John Radcliffe Hospital, Oxford. QJM 2008; 101: 365-9. (Pubitemid 351619244)
19. Raman M, Gramlich L, Whittaker S, et al. Canadian home total parenteral nutrition registry: preliminary data on the patient population. Can J Gastroenterol 2007; 21: 643-8. (Pubitemid 350200499)
20. Howard L, Ament M, Fleming CR, et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 1995; 109: 355-65.
21. Bakker H, Bozzetti F, Staun M, et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr 1999; 18: 135-40. (Pubitemid 29352027)
22. Lloyd DA, Vega R, Bassett P, et al. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment Pharmacol Ther 2006; 24: 1231-40. (Pubitemid 44427511)
23. Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999; 117: 1043-50. (Pubitemid 29512662)
24. Thompson JS, Iyer KR, DiBaise JK, et al. Short bowel syndrome and Crohn's disease. J Gastrointest Surg 2003; 7: 1069-72. (Pubitemid 37524075)
25. Agwunobi AO, Carlson GL, Anderson ID, et al. Mechanisms of intestinal failure in Crohn's disease. Dis Colon Rectum 2001; 44: 1834-7. (Pubitemid 34031441)
26. O'Keefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006; 4: 6-10. (Pubitemid 43129518)
27. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5-36.
28. Howard L, Heaphey L, Fleming CR, et al. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J Parenter Enteral Nutr 1991; 15: 384-93.
29. Chouraki V, Savoye G, Dauchet L, et al. The changing pattern of Crohn's disease incidence according to age in northern France: a continuing increase in the 10-19 year old age bracket (1988-2007). Aliment Pharmacol Ther 2011; 33: 1133-42.
30. Koffeman GI, van Gemert WG, George EK, et al. Classification, epidemiology and aetiology. Best Pract Res Clin Gastroenterol 2003; 17: 879-93.
31. Évaluation de la nutrition parentérale à domicile: état des lieux et modalité de prise en charge. Rapport de la Haute Autorité de Santé 2008. Available at: http://www.has-sante.fr. Accessed May 2008.
32. Gunesh S, Thomas GA, Williams GT, et al. The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005. Aliment Pharmacol Ther 2008; 27: 211-9.
33. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007; 13: 481-9. (Pubitemid 46668255)
34. Latour P, Louis E, Belaiche J,. Incidence of inflammatory bowel disease in the area of Liege: a 3 years prospective study (1993-1996). Acta Gastroenterol Belg 1998; 61: 410-3. (Pubitemid 29028650)
35. Sicilia B, Lopez Miguel C, Arribas F, et al. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain. Dig Liver Dis 2001; 33: 762-7. (Pubitemid 34071467)
36. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-41. (Pubitemid 40139240)
37. Lapidus A,. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006; 12: 75-81. (Pubitemid 43126087)
38. Beaugerie L, Brousse N, Bouvier AM, et al., CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-25.
39. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J, Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-6. (Pubitemid 43374514)
40. Loly C, Belaiche J, Louis E,. Predictors of severe Crohn's disease. Scand J Gastroenterol 2008; 43: 948-54.
41. Post S, Herfarth C, Bohm E, et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg 1996; 223: 253-60. (Pubitemid 26086716)
42. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-50. (Pubitemid 34784976)
43. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-82. (Pubitemid 33096034)
44. Papi C, Festa V, Fagnani C, et al. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis 2005; 37: 247-53. (Pubitemid 41070522)
45. Iesalnieks I, Kilger A, Glass H, et al. Intraabdominal septic complications following bowel resection for Crohn's disease: detrimental influence on long-term outcome. Int J Colorectal Dis 2008; 23: 1167-74.
46. Welsch T, Hinz U, Loffler T, et al. Early re-laparotomy for post-operative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn's disease. Int J Colorectal Dis 2007; 22: 1043-9. (Pubitemid 47500246)
47. Yamamoto T, Allan RN, Keighley MR,. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum 2000; 43: 1141-5. (Pubitemid 30626148)
48. Glehen O, Lifante JC, Vignal J, et al. Small bowel length in Crohn's disease. Int J Colorectal Dis 2003; 18: 423-7. (Pubitemid 37062734)
49. Nightingale JM, Lennard-Jones JE,. Adult patients with a short bowel due to Crohn's disease often start with a short normal bowel. Eur J Gastroenterol Hepatol 1995; 7: 989-91.
50. Nordgren S, McPheeters G, Svaninger G, et al. Small bowel length in inflammatory bowel disease. Int J Colorectal Dis 1997; 12: 230-4. (Pubitemid 27344516)
51. Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007; 50: 331-6. (Pubitemid 46393968)
52. Bouhnik Y, Lemann M, Mary JY, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-9. (Pubitemid 26035245)
53. Lemann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 2005; 128: 1812-8. (Pubitemid 40824692)
54. Angelico M, Della Guardia P,. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther 2000; 14 (Suppl 2): 54-7. (Pubitemid 30349082)
55. Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011; 60: 902-14.
56. Pironi L, Forbes A, Joly F, et al. Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology 2008; 135: 61-71. (Pubitemid 351916702)
57. Armuzzi A, De Pascalis B, Fedeli P, et al. Infliximab in Crohn's disease: early and long-term treatment. Dig Liver Dis 2008; 40: S271-9. (Pubitemid 351878071)
58. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 2008; 371: 660-7. (Pubitemid 351284485)
59. Punati J, Markowitz J, Lerer T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008; 14: 949-54.
60. Vermeire S, van Assche G, Rutgeerts P,. Review article: altering the natural history of Crohn's disease evidence for and against current therapies. Aliment Pharmacol Ther 2007; 25: 3-12. (Pubitemid 44902859)
61. Danese S, Colombel JF, Reinisch W, et al. Review article: infliximab for Crohn's disease treatment-shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther 2011; 33: 857-69.